James Andrea S.
SEC insider (Form 3/4/5 filer). CIK 0002027010. Chief Financial Officer at Insight Molecular Diagnostics Inc. (IMDX). 12 reported Form 4/5 transactions since Sep 2024; latest on Mar 26, 2026. Located in NASHVILLE, TN.
Companies James Andrea S. has filed insider reports for
- Insight Molecular Diagnostics Inc. (IMDX): Officer, Chief Financial Officer
James Andrea S.
CIK: 0002027010
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Insight Molecular Diagnostics Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Mar 26, 2026IMDX
Insight Molecular Diagnostics Inc.
ExerciseDirect28.3K shares- - Mar 26, 2026IMDX
Insight Molecular Diagnostics Inc.
Tax PaymentDirect11.3K shares at avg. $4.11$46K - Oct 31, 2025IMDX
Insight Molecular Diagnostics Inc.
Tax PaymentDirect12.2K shares at avg. $6.01$73K - Oct 31, 2025IMDX
Insight Molecular Diagnostics Inc.
ExerciseDirect50K shares- - Oct 31, 2025IMDX
Insight Molecular Diagnostics Inc.
DispositionDirectRestricted Stock Units
50K shares- - Sep 28, 2025IMDX
Insight Molecular Diagnostics Inc.
AwardDirectOption to Purchase Common Stock
235K shares- - Mar 26, 2025OCX
Oncocyte Corp
AwardDirectRestricted Stock Units
113.2K shares- - Feb 7, 2025OCX
Oncocyte Corp
PurchaseDirect97.6K shares at avg. $2.05$200K - Dec 5, 2024OCX
Oncocyte Corp
PurchaseDirect20K shares at avg. $2.29$46K - Oct 11, 2024OCX
Oncocyte Corp
AwardDirectOptions to Purchase Common Stock
200K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 26, 2026 | IMDX Insight Molecular Diagnostics Inc. | Exercise | 28,302 | - | $0 | Direct |
| Mar 26, 2026 | IMDX Insight Molecular Diagnostics Inc. | Tax Payment | 11,298 | $4.11 | $46,435 | Direct |
| Oct 31, 2025 | IMDX Insight Molecular Diagnostics Inc. | Tax Payment | 12,175 | $6.01 | $73,172 | Direct |
| Oct 31, 2025 | IMDX Insight Molecular Diagnostics Inc. | Exercise | 50,000 | - | - | Direct |
| Oct 31, 2025 | IMDX Insight Molecular Diagnostics Inc. | Disposition Restricted Stock Units | 50,000 | - | - | Direct |
| Sep 28, 2025 | IMDX Insight Molecular Diagnostics Inc. | Award Option to Purchase Common Stock | 235,000 | - | - | Direct |
| Mar 26, 2025 |  OCX Oncocyte Corp | Award Restricted Stock Units | 113,207 | - | - | Direct |
| Feb 7, 2025 | OCX Oncocyte Corp | Purchase | 97,561 | $2.05 | $200,000 | Direct |
| Dec 5, 2024 | OCX Oncocyte Corp | Purchase | 20,000 | $2.29 | $45,800 | Direct |
| Oct 11, 2024 | OCX Oncocyte Corp | Award Options to Purchase Common Stock | 200,000 | - | - | Direct |
1-10 of 12 transactions